10 medicines held by pharmaand GmbH on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Anafranil SR 75 mg Prolonged-release Tablets PA23086/001/001 |
Clomipramine hydrochloride | pharmaand GmbH | Marketed |
| EMSELEX EU/1/04/294/1-12 |
Darifenacin hydrobromide | pharmaand GmbH | — |
| Farydak 10 mg hard capsules EU/1/15/1023/001-003 |
Panobinostat | pharmaand GmbH | — |
| Farydak 15 mg hard capsules EU/1/15/1023/004-006 |
Panobinostat | pharmaand GmbH | — |
| Farydak 20 mg hard capsules EU/1/15/1023/007-009 |
Panobinostat | pharmaand GmbH | — |
| Pegasys 135 micrograms solution for injection in pre-filled syringe EU/1/02/221/005-006 |
Peginterferon-alfa-2a | pharmaand GmbH | — |
| Pegasys 180 micrograms solution for injection EU/1/02/221/003-004 |
Peginterferon-alfa-2a | pharmaand GmbH | — |
| Rubraca 200 mg Film-coated tablet EU/1/17/1250/001 |
Rucaparib camsylate | pharmaand GmbH | — |
| Rubraca 250 mg Film-coated tablet EU/1/17/1250/002 |
Rucaparib camsylate | pharmaand GmbH | — |
| Rubraca 300 mg Film-coated tablet EU/1/17/1250/003 |
Rucaparib camsylate | pharmaand GmbH | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.